Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-02-20
2010-06-22
Kosar, Andrew D (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S328000, C514S825000, C514S826000, C514S886000
Reexamination Certificate
active
07741292
ABSTRACT:
A method of inhibiting the emigration of cells from the intravascular compartment into tissues (or through any membrane limiting any body compartment from another) by confronting the cells with an agonist specific for receptors involved with migration of said cells via a receptor thereby making the cell unresponsive to further activation.
REFERENCES:
patent: 6140064 (2000-10-01), Loetscher et al.
patent: EP 1 167 527 (2002-01-01), None
patent: 1 167 527 (2002-01-01), None
patent: WO 99/47158 (1999-09-01), None
Detheux, 2000, J. Exp. Med., 192, 1501-1508.
Schulz-Knappe, 1996, J. Exp. Med., 183, 295-299.
Mosier, 1999, Journal of Virology, 73, 3544-3550.
Detheux, M., et al., “Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties,” The Journal of Experimental Medicine, vol. 192, No. 10, Nov. 20, 2000, pp. 1501-1508, [XP002241991].
Muench, J., et al., “Hemofiltrate CC chemokine 1(9-74) causes effective internalization of CCR5 and is a potent inhibitor of R5-tropic human immunodeficiency virus type 1 strains in primary T cells and macrophages,” Antimicrobial Agents and Chemotherapy, vol. 46, No. 4, Apr. 2002, pp. 982-990, [XP002241992].
Teran, L. M., “CCL Chemokines and asthma,” Immunology Today, vol. 21, No. 5, May 2000, pp. 235-242, [XP004198513].
Mosier et al., “High Potent RANTES Analogues either Prevent CCR5-Using Human Immunodeficiency Virus Type 1 Infection In Vivo or Rapidly Select for CXCR4-Using Variants”Journal of Virology, 73(5):3544-3550 (May 1999).
Elsner Jörn
Escher Sylvia
Forssmann Ulf
Spodsberg Nikolaj
Gudibande Satyanarayana R
IPF Pharmaceuticals GmbH
Jacobson & Holman PLLC
Kosar Andrew D
LandOfFree
Method of inhibiting the emigration of cells from the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting the emigration of cells from the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting the emigration of cells from the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4244973